Form D · Pharmaceuticals
Virpax Pharmaceuticals, Inc.
Berwyn, PA · CIK 0001708331
Offering snapshot reported Jul 12, 2024 · SEC filing
- Reported sold
- $2.5M Offering amount: $2.5M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 5, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 12, 2024 | Initial | $2,500,000 | No comparison | 1 | SEC filing |
| Apr 5, 2018 | Initial | $1,379,000 | No comparison | 8 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-518634
Source: Form D, filed Jul 12, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Gerald Bruce | Director, Executive |
| Jatinder Dhaliwal | Director |
| Katharyn Field | Director |
| Eric Floyd | Director |
| Jeffrey Gudin | Director, Executive |
| Gary Herman | Director |
| Thani Jambulingam | Director |
| Anthony Mack | Director, Executive |
| Sheila Mathias | Executive |
| Jerrold Sendrow | Director |
| Vinay Shah | Executive |
| Vanila M. Singh | Director |
| Judy Su | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1055 Westlakes Drive, Suite 300
Berwyn, PA, 19312
Berwyn, PA, 19312